FIELD: pharmaceutical technology. SUBSTANCE: new medicinal composition has, wt. -% : metronidazol hemisuccinate 25.92-26.06 (as for metronidazol); N-methylglucamine 29.52-29.73; mannitol 41.52-41.76, and phosphate buffer pH = 5.5-6.5 - the rest. EFFECT: increased bioavailability.
| Title | Year | Author | Number |
|---|---|---|---|
| STABLE PHARMACEUTICAL COMPOSITION BASED ON ACTINOMYCIN D FOR INJECTIONS | 2014 |
|
RU2587716C2 |
| METHOD FOR PREPARING METRONIDASOL SOLUTION FOR INJECTIONS | 2003 |
|
RU2245135C1 |
| INJECTION MEDICINAL FORM OF METRONIDAZOLE | 2000 |
|
RU2173993C1 |
| PREPARATION BASED UPON HUMAN RECOMBINANT ALPHA-2-INTERFERON FOR INJECTIONS IN DRY LYOPHILIZED FORM | 2002 |
|
RU2236866C2 |
| PHARMACEUTICAL PREPARATION CONTAINING GROWTH HORMONE OR GROWTH HORMONE DERIVATIVE AND HISTIDINE OR HISTIDINE DERIVATIVE, A PREPARATION THAT IS GROWTH HORMONE CRYSTALS CONTAINING HISTIDINE OR HISTIDINE DERIVATIVE AND A METHOD OF PREPARING GROWTH HORMONE CRYSTALS AND HISTIDINE OR HISTIDINE DERIVATIVE | 1992 |
|
RU2122426C1 |
| SYNERGISTIC SUPPOSITORIES FOR INFECTIOUS GYNECOPATHIES TREATMENT (VERSIONS) | 2007 |
|
RU2356535C2 |
| MEDICINAL PREPARATION FOR TREATMENT OF MUSCLE DYSTONIA AND METHOD FOR ITS PREPARING | 2002 |
|
RU2206337C1 |
| METHOD FOR PRODUCING A SUBSTANCE OF THE RECOMBINANT L-ASPARAGINASE FROM ERWINIA CAROTOVORA | 2010 |
|
RU2441914C1 |
| ANESTHETIC COMPOSITION AND METHOD OF EYE ANESTHETIZATION | 2020 |
|
RU2812900C2 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR THE TREATMENT OF PURULENT WOUNDS ON THE BASIS OF FLUOROQUINOLONS (OPTIONS) | 2016 |
|
RU2682171C2 |
